25 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates … HIPAA, CCPA, and the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) (collectively, the “Privacy Laws”). To ensure
6-K
EX-99.1
mgvt1bbntlm v9cy0el
1 Mar 21
Report of Foreign Private Issuer
7:58am
6-K
EX-1.1
cz2j49 8j
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
u4grd vwsl4dnki
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
w91y6r gs1g
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
jwxv3q a3k1g
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
uqhv3lswdnfipmu1kq
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
kqxsrg
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
2oa 8p1pzwaf5
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
no5c hrgh8h1766xx
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
pu11u
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
1kb7 bpln7egoq
19 Nov 18
Agreement and Plan of Merger
4:34pm